GENETEC CORPORATION (4492.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	10.1B	11.0B	8.1B	7.1B	5.9B
Cost of Revenue	1.6B	6.8B	4.9B	4.2B	3.5B
Gross Profit	923.6M	4.1B	3.3B	2.9B	2.3B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	899.0M	3.3B	2.6B	2.3B	2.2B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	899.0M	3.3B	2.6B	2.3B	2.2B
Cost and Expenses	9.6B	10.2B	7.4B	6.5B	5.8B
Operating Income (EBIT)	591.0M	820.0M	693.0M	629.0M	105.0M
Non-Operating
Interest Income	15.0K	2.7M	472.0K	13.0K	89.0K
Interest Expense	7.7M	30.7M	11.2M	7.2M	3.4M
Net Interest Income	(7.7M)	(28.0M)	(10.7M)	(7.1M)	(3.3M)
Other Non-Op Income/Expense	13.5M	4.4M	(10.1M)	5.7M	5.8M
Non-Operating Income (excl Interest)	21.2M	39.1M	3.1M	19.2M	17.2M
EBT (Pre-Tax Income)	43.1M	826.8M	662.1M	629.6M	87.9M
Income Tax Expense	25.8M	316.3M	240.9M	214.8M	64.2M
Bottom Line
Net Income	393.0M	510.0M	421.0M	414.0M	23.0M
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	393.0M	510.0M	421.0M	414.0M	23.0M
Per Share
Basic EPS	¥34	¥44	¥37	¥36	¥6
Diluted EPS	¥34	¥44	¥36	¥36	¥6
Revenue Per Share	¥880	¥952	¥710	¥628	¥1,555
Shares
Basic Shares Outstanding	11.5M	11.5M	11.4M	11.4M	3.8M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	909.5M	751.4M	695.6M	220.4M
D&A	—	89.5M	58.4M	66.6M	115.4M
EBIT	591.0M	820.0M	693.0M	629.0M	105.0M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026